Dynamin-1 is a potential mediator in cancer-related cognitive impairment
Dynamin-1 (DNM1) is crucial for synaptic activity, neurotransmission, and associative memory, positioning it as a potential biomarker of cancer-related cognitive impairment (CRCI), a neurological consequence of cancer treatment characterized by memory loss, poor concentration, and impaired executive...
Saved in:
| Main Authors: | Ding Quan Ng, Casey Hudson, Tracy Nguyen, Sukesh Kumar Gupta, Yong Qin Koh, Munjal M. Acharya, Alexandre Chan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Neurotherapeutics |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1878747924001673 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy
by: Delphine Trochet, et al.
Published: (2017-12-01) -
Cancer-Related Cognitive Impairments (CRCIs) in Non-Central Nervous System Adult Patients: Outcome Measures and Methodology of Assessment: A Literature Review
by: Andrea Pace, et al.
Published: (2024-11-01) -
Doxorubicin causes cognitive impairment and alters gut microbiota in both male and female juvenile rats
by: Chadni Patel, et al.
Published: (2025-07-01) -
Exploring the reality of exosomes in dermatology
by: Taciana Dal'Forno-Dini, et al.
Published: (2025-03-01) -
Progress, challenges, and prospects of small extracellular vesicles isolation and characterization
by: Hongyan Yin, et al.
Published: (2024-06-01)